[Use of tranexamic acid, AMCA for the improvement of hemorrhagic manifestations in hemophilia].
D000293:Adolescent; D000328:Adult; D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D006467:Hemophilia A / Q000188:drug therapy*; D006470:Hemorrhage / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011517:Prothrombin Time; D013916:Thrombelastography
D000933:Antifibrinolytic Agents; D003509:Cyclohexanecarboxylic Acids
Pouzitĩ tranexamove kyseliny, AMCA, k snĩzenĩ krvãcivych projevů u hemofilie.